
β‑Nicotinamide Mononucleotide (NMN) (≥99.9%) | 1094‑61‑7
Our β‑Nicotinamide Mononucleotide (NMN) is produced using an advanced bio‑enzyme catalysis technology, a green and sustainable process that eliminates harmful chemical residues while ensuring exceptional product safety. This proprietary method delivers ≥99.9% purity and endotoxin levels below 0.1 EU/mg.
Specification
|
|
|
|
|
|
|
|
|
|
|
|
Our Competitive Advantages
Bio‑Enzyme Catalysis – Environmentally friendly, residue‑free, and highly efficient production.
Ultra‑High Purity – ≥99.9%, ensuring maximum bioactivity and minimal impurities.
Batch Consistency & Traceability – Full quality control from raw materials to final product.
All ingredients from Genvera Labs are manufactured using advanced synthetic biology platforms, ensuring ultra‑high purity, batch‑to‑batch consistency, and full traceability.
We don’t just meet specifications—we engineer them.